The U.S. Food and Drug Administration (FDA) issued new draft guidance on October 29, 2025, proposing what it said were “major updates to ...

Last week, FDA released draft guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: ...

By emphasizing analytical studies instead of routine clinical trials, the FDA signals its intent to reduce the cost (often estimated at $100 million to $300 million) and time (typically 6–9 years) ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind ...

This article compares the global pharmacovigilance standards with the practices followed in Saudi Arabia. It highlights similarities, differences, and areas where the Kingdom has made progress or ...

Detailed price information for Bionxt Solutions Inc. (BNXT-CN) from The Globe and Mail including charting and trades.

Madagascar Invest releases a comparative study highlighting how Madagascar and the Philippines tell two very different stories of lifestyle, business, and investment potential shaped by reform, growth ...